Hardik Joshi, Pragna Shelat, Divyang Dave
Hardik Joshi1*, Dr. Pragna Shelat2, Dr. Divyang Dave2
1PhD Scholar, Kadi Sarva Vishwavidyalaya, Gandhinagar, Gujarat, India.
2K.B. Institute of Pharmaceutical Education and Research, Kadi Sarva Vishwavidyalaya, Gadhinagar, Gujarat, India.
Volume - 13,
Issue - 9,
Year - 2020
Prednisolone acetate is a topical anti-inflammatory agent used in the treatment of steroid responsive inflammation of palpeberal and bulber conjunctiva, cornea and anterior segments of the globe. The aim of the present work is to optimize and characterize lipid based nano emulsion of a poorly water-soluble drug, Prednisolone acetate. Lipid based nanoemulsion was prepared using micro fluidization process. Solubility studies were carried out to identify suitable oil and surfactant. A three level three factor Box-Behenken design was used to optimize lipid based nano emulsion. Prepared formulation was characterized for drug content, pH, globule size, zeta potential, polydispersity index, osmolality and in vitro drug release study by dialysis method using bottle apparatus. Eye irritation study was carried out by Hen’s egg chorioallantoic Membrane test. Stability study of the prepared formulation was performed as per ICH guidelines. Prepared nanoemulsion is transparent with a blue tinge. Optimized batch of lipid based nanoemulsion showed average globule size of 110nm with a poly dispersity index less than 0.11. The results of in vitro drug release study suggest more than 90% drug release over a period of 12h. Developed formulation was found to be non-irritant and stable when stored at 40°C and can be used for ophthalmic delivery.
Cite this article:
Hardik Joshi, Pragna Shelat, Divyang Dave. Optimization and Characterization of Lipid Based Nano Emulsion of Prednisolone Acetate for Ophthalmic Drug Delivery. Research J. Pharm. and Tech 2020; 13(9):4139-4147. doi: 10.5958/0974-360X.2020.00731.3
1. Sarker DK. Engineering of Nanoemulsions for Drug Delivery. Current Drug Delivery. 2005(2):297-310.
2. Sheikh Shafiq FS, Sushma Talegaonkar, Farhan J. Ahmad, Roop K. Khar, Mushir Ali. Development and bioavailability assessment of ramipril nanoemulsion formulation. European Journal of Pharmaceutics and Biopharmaceutics. 2007; 66:227-43.
3. Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Progress in Retinal and Eye Research. 2002; 21:15-34.
4. Masazumi Yamaguchi S-iY, Akiharu Isowaki, Makiko Yamamoto, Masako Kimura, Katsuhiro Inada, Akira Ohtori. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. International Journal of Pharmaceutics. 2005; 301:121–8.
5. Yan Liu XLaXT. Lipid emulsions as a potential delivery system for ocular use of azithromycin. Drug Development and Industrial Pharmacy. 2009; 35(7):887–96.
6. Li Gan JW, Min Jiang, Hanah Bartlett, Defang Ouyang, Frank Eperjesi, Jianping Liu and Yong Gan. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discovery Today. 2013; 18(5/6):290-7.
7. Feng-Feng Lv L-QZ, Chen-Ho Tung. Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. International Journal of Pharmaceutics 2005; 301:237–46.
8. Yusuke Sakai S-IY, Akira Ohtori. Stability of latanoprost in an ophthalmic lipid emulsion using polyvinyl alcohol. International Journal of Pharmaceutics. 2005; 305:176–9.
9. Shunmugaperumal Tamilvanana SB. The potential of lipid emulsion for ocular delivery of lipophilic drugs. European Journal of Pharmaceutics and Biopharmaceutics. 2004; 58:357–68.
10. F. Lallemand OF-B, K. Besseghir, F. Behar-Cohen, R. Gurny. Cyclosporine A delivery to the eye: A pharmaceutical challenge. European Journal of Pharmaceutics and Biopharmaceutics 2003; 56:307–18.
11. Sah PKSaAK. Patent Perspectives for Corticosteroids Based Ophthalmic Therapeutics. Recent Patents on Drug Delivery & Formulation. 2014(8):206-23.